• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫代硫酸钠治疗非甲状旁腺功能亢进血液透析患者的肿瘤性钙化

Sodium thiosulfate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism.

作者信息

Papadakis J T, Patrikarea A, Digenis G E, Stamatelou K, Ntaountaki I, Athanasopoulos V, Tamvakis N

机构信息

Renal Unit, NIMTS Hospital, Athens, Greece.

出版信息

Nephron. 1996;72(2):308-12. doi: 10.1159/000188861.

DOI:10.1159/000188861
PMID:8684546
Abstract

Extraskeletal tumoral calcifications (TC) may occur in patients with end-stage renal disease. The TC usually develop in the presence of secondary hyperparathyroidism or a high calcium x phosphate product, while other factors have been also occasionally implicated in their development. At present, no uniformly accepted effective treatment has been described for this condition. We describe a 58-year-old female patient with end-stage renal disease who 7 years after the onset of dialysis presented with pain and movement restriction of various joints. A skeletal X-ray showed huge amounts of periarticular TC. The TC occurred in the absence of hyperparathyroidism or a high calcium x phosphate product as evidenced by hormonal and biochemical examination as well as by a bone biopsy specimen that revealed an adynamic bone disease with significant aluminum staining. Sodium thiosulfate, an inorganic salt that has been claimed to inhibit the formation and to favor the solubility and the mobilization of calcified masses, was administered to the patient, and after a long period of treatment considerable radiological regression of the TC with concurrent clinical recovery was noticed. Aluminum intoxication, along with other factors, was considered to be the cause of TC development. The use of sodium thiosulfate seemed to be a reasonable nonspecific therapeutic approach for the management of TC in this case.

摘要

肾外肿瘤性钙化(TC)可发生于终末期肾病患者。TC通常在继发性甲状旁腺功能亢进或高钙×磷乘积的情况下发生,而其他因素偶尔也与它们的发生有关。目前,尚未有针对这种情况的统一公认的有效治疗方法。我们描述了一名58岁的终末期肾病女性患者,透析开始7年后出现多个关节疼痛和活动受限。骨骼X线显示关节周围有大量TC。激素和生化检查以及骨活检标本显示为无动力性骨病且有明显铝染色,这表明TC是在没有甲状旁腺功能亢进或高钙×磷乘积的情况下发生的。给患者使用了硫代硫酸钠,一种据称可抑制钙化肿块形成并促进其溶解和移动的无机盐,经过长期治疗后,发现TC有明显的放射学消退,同时临床症状也有所恢复。铝中毒以及其他因素被认为是TC发生的原因。在这种情况下,使用硫代硫酸钠似乎是一种合理的非特异性治疗TC的方法。

相似文献

1
Sodium thiosulfate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism.硫代硫酸钠治疗非甲状旁腺功能亢进血液透析患者的肿瘤性钙化
Nephron. 1996;72(2):308-12. doi: 10.1159/000188861.
2
Sodium thiosulfate treatment of tumoral calcinosis in patients with end-stage renal disease.硫代硫酸钠治疗终末期肾病患者的肿瘤性钙化症。
Ren Fail. 1990;12(4):213-9. doi: 10.3109/08860229009060727.
3
Tumoral calcifications in hemodialysis patients: possible role of aluminum intoxication.血液透析患者的肿瘤性钙化:铝中毒的可能作用。
Nephron. 1992;60(3):260-7. doi: 10.1159/000186763.
4
Tumoral calcinosis in hemodialysis patients. A review of three cases.血液透析患者的肿瘤性钙化。三例病例回顾。
Rev Rhum Engl Ed. 1997 Jan;64(1):59-62.
5
Periarticular tumoral calcinosis and hypercalcemia in a hemodialysis patient without hyperparathyroidism: a case report.一名无甲状旁腺功能亢进的血液透析患者出现关节周围肿瘤性钙化和高钙血症:病例报告
J Nucl Med. 1990 Jun;31(6):1099-103.
6
Massive, painful tumoral calcinosis in a long-term hemodialysis patient.一名长期血液透析患者出现巨大、疼痛性肿瘤性钙化。
Hemodial Int. 2011 Oct;15(4):577-80. doi: 10.1111/j.1542-4758.2011.00581.x. Epub 2011 Aug 12.
7
Renal ostodystrophy during the developing stage of maintenance dialysis in Transylvania. Early development of periarticular calcifications and beta 2 microglobulin amyloidosis in spite of a relatively good prevention of secondary hyperparathyroidism.特兰西瓦尼亚维持性透析发展阶段的肾性骨营养不良。尽管继发性甲状旁腺功能亢进得到了较好的预防,但关节周围钙化和β2微球蛋白淀粉样变仍早期出现。
Ann Med Interne (Paris). 1998 Mar;149(2):67-75.
8
Intravenous sodium thiosulfate combined with parathyroidectomy as a cure for uremic tumoral calcinosis in a hemodialysis patient.静脉注射硫代硫酸钠联合甲状旁腺切除术治疗一名血液透析患者的尿毒症性肿瘤性钙化症。
Joint Bone Spine. 2021 Jan;88(1):105043. doi: 10.1016/j.jbspin.2020.06.016. Epub 2020 Jul 1.
9
Tumoral calcinosis: Diffuse multifocal form in hemodialysis patients. Two case reports.肿瘤性钙化症:血液透析患者中的弥漫性多灶性形式。两例病例报告。
Orthop Traumatol Surg Res. 2017 Sep;103(5):815-820. doi: 10.1016/j.otsr.2017.01.018. Epub 2017 May 30.
10
[Posttransplant regression of uremic tumoral calcinosis].[尿毒症性肿瘤性钙化症移植后消退]
Nefrologia. 2007;27(3):378-81.

引用本文的文献

1
Treatment of Severe Tumoral Calcinosis with Teriparatide in a Dialysis Patient after Total Parathyroidectomy.全甲状旁腺切除术后透析患者使用特立帕肽治疗严重肿瘤性钙化症
Case Rep Nephrol. 2021 Jan 6;2021:6695906. doi: 10.1155/2021/6695906. eCollection 2021.
2
Sodium thiosulfate: an emerging treatment for calciphylaxis in dialysis patients.硫代硫酸钠:一种用于透析患者钙化防御的新兴治疗方法。
Case Rep Nephrol Dial. 2015 Mar 13;5(1):77-82. doi: 10.1159/000380945. eCollection 2015 Jan-Apr.
3
Sodium thiosulfate therapy for calcific uremic arteriolopathy.
硫代硫酸钠治疗钙化性尿毒症性小动脉病。
Clin J Am Soc Nephrol. 2013 Jul;8(7):1162-70. doi: 10.2215/CJN.09880912. Epub 2013 Mar 21.
4
Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy.硫代硫酸钠对终末期肾病血管钙化的影响:一项可行性、安全性和疗效的初步研究。
Am J Nephrol. 2011;33(2):131-8. doi: 10.1159/000323550. Epub 2011 Jan 17.
5
Tumoral calcinosis (Teutschlander disease) in a dialysis patient.一名透析患者的肿瘤性钙化症(特施兰德病)。
Indian J Nephrol. 2008 Jul;18(3):122-4. doi: 10.4103/0971-4065.43692.
6
Thiosulfate reduces calcium phosphate nephrolithiasis.硫代硫酸盐可减轻磷酸钙肾结石。
J Am Soc Nephrol. 2009 Jun;20(6):1246-53. doi: 10.1681/ASN.2008070754. Epub 2009 Apr 15.